Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related LRCX
Earnings Scheduled For January 28, 2015
Credit Suisse Raises Price Target On Lam Research
Related DVAX
Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4
William Blair's Top BioPharma Stock Picks For Q1 2015
Oversight board recommends continuing Heplisav-B Phase 3 trial (Seeking Alpha)

Analysts at DA Davidson initiated coverage on shares of Lam Research (NASDAQ: LRCX) with a “buy” rating. Lam Research's shares closed at $36.13 on Monday. Lam Research's trailing-twelve-month operating margin is 9.03%.

JP Morgan initiated coverage on shares of Dynavax Technologies (NASDAQ: DVAX) with a “neutral” rating. Dynavax's shares closed at $2.85 on Monday. Dynavax's trailing-twelve-month revenue is $19.33 million.

Credit Suisse initiated coverage on shares of Alon USA Energy (NYSE: ALJ) with a “neutral” rating. Alon USA Energy's stock closed at $18.09 on Monday. Alon USA Energy's PEG ratio is 0.87.

Analysts at BMO Capital initiated coverage on shares of Abbott Laboratories (NYSE: ABT) with an “outperform” rating. Abbott's shares closed at $31.34 on Monday. Abbott's trailing-twelve-month ROE is 25.21%.

Latest Ratings for LRCX

DateFirmActionFromTo
Jan 2015JefferiesMaintainsBuy
Jan 2015Credit SuisseMaintainsOutperform
Jan 2015JP MorganMaintainsOverweight

View More Analyst Ratings for LRCX
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ABT + ALJ)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga PRO content